- Home
- Profiles


Noam Harpaz, MD
Anatomic Pathology and Clinical Pathology
- About Me
- Clinical Focus
- Education & Certifications
- Insurance
- Publications
- Industry Relationships
About Me
Clinical Interest
Gastrointestinal pathology, general surgical pathology, and diagnostic immunopathology.
Language
Position
Hospital Affiliations
- The Mount Sinai Hospital
About Me
Clinical Interest
Gastrointestinal pathology, general surgical pathology, and diagnostic immunopathology.
Language
Position
Hospital Affiliations
- The Mount Sinai Hospital
About Me
Clinical Interest
Gastrointestinal pathology, general surgical pathology, and diagnostic immunopathology.
Language
Position
Hospital Affiliations
- The Mount Sinai Hospital
Clinical Focus
- Anal Cancer
- Barrett's Esophagus
- Celiac Disease
- Colon Polyps
- Colorectal Cancer
- Colorectal Resection
- Crohn's Disease
- Diverticulitis
- Esophageal Cancer
Show More
- Anal Cancer
- Barrett's Esophagus
- Celiac Disease
- Colon Polyps
- Colorectal Cancer
- Colorectal Resection
- Crohn's Disease
- Diverticulitis
- Esophageal Cancer
- Esophagectomy
- Gastrectomy
- Gastritis
- Inflammatory Bowel Disease
- Ischemic Bowel Disease
- Peptic Ulcer
- Small Bowel Resection
- Stomach Cancer
- Ulcerative Colitis
- Upper GI Endoscopy
Education
PhD, Feinberg Graduate School Weizmann Institute of Science
, Hospital for Sick Children
MD, University of Miami School of Medicine
MD, Universite St. Esprit de Kaslik-USEK
, Mount Sinai School of Medicine
, St. Mark's Hospital
Residency, Pathology
Mount Sinai Hospital
Certifications
American Board of Pathology
Insurance Information
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Publications
Selected Publications
- Colorectal dysplasia in chronic inflammatory bowel disease: a contemporary consensus classification and interobserver study. Noam Harpaz, John R. Goldblum, Neil A. Shepherd, Robert H. Riddell, Carlos A. Rubio, Michael Vieth, Helen H. Wang, Robert D. Odze. Human Pathology
- Aberrant p53 expression is associated with neoplastic progression in Barrett oesophagus diagnosed as indefinite for dysplasia. Xiuxu Chen, Bella Lingjia Liu, Noam Harpaz, Hongfa Zhu, Alexandros D. Polydorides, Qingqing Liu. Histopathology
- Lifestyle, behaviour, and environmental modification for the management of patients with inflammatory bowel diseases: an International Organization for Study of Inflammatory Bowel Diseases consensus. Ashwin N. Ananthakrishnan, Gilaad G. Kaplan, Charles N. Bernstein, Kristin E. Burke, Paul J. Lochhead, Alexa N. Sasson, Manasi Agrawal, Jimmy Ho Tuan Tiong, Joshua Steinberg, Wolfgang Kruis, Flavio Steinwurz, Vineet Ahuja, Siew C. Ng, David T. Rubin, Jean Frederic Colombel, Richard Gearry, M. Abreu, V. Ahuja, M. Allez, A. Ananthakrishnan, W. Bemelman, C. Bernstein, J. Braun, Y. Chowers, J. F. Colombel, S. Danese, G. D'Haens, A. D'Hoore, A. Dignass, I. Dotan, M. Dubinsky, A. Ekbom, P. Fleshner, C. Gasche, M. A. Gassull, S. Ghosh, P. Gibson, A. Griffiths, J. Halfvarson, S. Hanauer, N. Harpaz, A. Hart, T. Hibi, M. Kamm, G. Kaplan, A. Kaser, B. Korelitz, P. Kotze, D. Sachar, B. Sands. The Lancet Gastroenterology and Hepatology
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Harpaz during 2022 and/or 2023. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting:
- Eli Lilly and Company
Other activities: Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
- AbbVie Inc.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.